Diagnosing and managing scleroderma-related pulmonary arterial hypertension

被引：4

作者：

Athanasiou, Katherine Alexis ^{[1
,2
]}

Sahni, Sonu ^{[3
,4
]}

Rana, Amrinder ^{[3
,4
]}

Talwar, Arunabh ^{[3
,4
]}

机构：

[1] Arthrit Inst Long Isl, Rheumatol, Hicksville, NY 11801 USA

[2] Northwell Hlth Syst, New Hyde Pk, NY 11040 USA

[3] Dept Pulm Crit Care & Sleep Med, New Hyde Pk, NY USA

[4] Adv Lung Dis Ctr, New Hyde Pk, NY USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2017年 / 30卷 / 09期

关键词：

pulmonary arterial hypertension; scleroderma; systemic sclerosis; autoimmune disease; right heart catheterization; vasodilation; RECEPTOR ANTAGONIST BOSENTAN; SYSTEMIC-SCLEROSIS; RISK-FACTORS; DOUBLE-BLIND; DISEASE; ECHOCARDIOGRAPHY; TREPROSTINIL; PREDICTORS; SURVIVAL; EXERCISE;

D O I：

10.1097/01.JAA.0000522129.93995.13

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Scleroderma is an uncommon autoimmune disease of unknown cause that may affect any organ system in the body. Patients with scleroderma are prone to developing pulmonary complications, including pulmonary arterial hypertension (PAH), that are the leading cause of death in this population. This article describes scleroderma-related PAH and its diagnosis and management.

引用

页码：11 / 18

页数：8

共 50 条

[21] Determinants of pulmonary arterial hypertension in scleroderma
Plastiras, Sotiris C.
Karadimitrakis, Stylianos P.
Kampolis, Christos
Moutsopoulos, Haralampos M.
Tzelepis, George E.
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2007, 36 (06) : 392 - 396
[22] Hemodynamics Should Be the Primary Approach to Diagnosing, Following, and Managing Pulmonary Arterial Hypertension
Maron, Bradley A.
CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (04) : 515 - 520
[23] ROLE OF SPIROMETRY IN SURVIVAL PREDICTION IN SCLERODERMA RELATED PULMONARY ARTERIAL HYPERTENSION
Keogh, K. A.
Kane, G. C.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 707 - 708
[24] Refractory Hypoxemia in a Patient with Scleroderma Related Pulmonary Arterial Hypertension and Myocarditis
Graziani, C.
Richards, K. L.
Guy, E. S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[25] Endothelin Receptor AntagonismRole in the Treatment of Pulmonary Arterial Hypertension Related to Scleroderma
Peter Kabunga
Gerry Coghlan
Drugs, 2008, 68 : 1635 - 1645
[26] ANA Pattern and Clinical Features in Patients with Scleroderma-Related Pulmonary Disease
Pandya, D.
Khan, K. Z.
Simonson, J. L.
Talwar, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[27] SCLERODERMA-RELATED PULMONARY HYPERTENSION: COMPARISON OF BASELINE CHARACTERISTICS AND PROGNOSIS BETWEEN PATIENTS WITH LCSSc VS dcSSc
Fernandez, A.
Simeon, C. P.
Fonollosa, V.
Fernandez Codina, A.
Prado, F. J.
Sarria, A.
Vilardell, M.
RHEUMATOLOGY, 2012, 51 : 97 - 97
[28] SCLERODERMA-RELATED ILD REVIEW
Doyle, Dominic
Henry, Michael
IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 5) : 165 - 165
[29] Properly Diagnosing Pulmonary Arterial Hypertension
Preston, Ioana R.
AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (08): : 2C - 9C
[30] Huge aspergilloma developed within a zone of scleroderma-related pulmonary fibrosis
Rakotoson, J. L.
Vololontiana, H. M. D.
Raherison, R. E.
Andrianasolo, R. L.
Rakotomizao, J. R.
Rakotoharivelo, H.
Rajaoarifetra, J.
Randria, M. J. D.
Rapelanoro, R. F.
Andrianarisoa, A. C. F.
Rajaona, H. R.
REVUE DE PNEUMOLOGIE CLINIQUE, 2012, 68 (01) : 31 - 35

← 1 2 3 4 5 →